$ACN

Accenture Stock: Is ACN Underperforming the Technology Sector?

Accenture (ACN) has underperformed IBM, with a 21.2% YTD decline and 5% loss over 52 weeks. Analysts give ACN a 'Moderate Buy' rating, with a mean price target of $185.64 and a high target of $275, implying 45% upside potential.

Original reporting
Published Sep 1, 2026, 11:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 1, 2026, 11:33 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Accenture Stock: Is ACN Underperforming the Technology Sector? — source image
Decision brief

The 30-second read

$ACNBullishMed
01

Why it matters

Analyst upgrades could reverse underperformance if investors act on the new targets.

02

Market read

New price target data provides a fresh catalyst for ACN traders.

03

What to watch

Potential macro headwinds and competitive pressure from IBM.

Relevance 6/10Novelty 6/10Timing: current

Background

Accenture is lagging its sector with a 21.2% YTD decline, prompting analysts to highlight upside.

Company-level read

Ticker impact

$ACNBullishMedium confidence
Context

Accenture (ACN) has a consensus "Moderate Buy" rating and a new mean price target of $185.64 with a street-high target of $275, indicating a 45% upside.

Expected impact

Potential price appreciation toward $275 if market digests the target.

Evidence & confidence

The new price target reflects bullish analyst sentiment and provides a concrete upside metric for traders.

Market effects

Higher target may lift other technology services peers.

US technology sector could see modest support.

Limited to investors tracking IT services.

Counterpoint

Price targets may be overly optimistic given recent underperformance.

Key entities

  • Accenture

    Global professional services firm (ticker ACN).

Related articles

$ACNMed

Consulting sector outlook: Accenture leads on AI monetization and ROIC

Consulting sector sentiment is cautiously optimistic, with Accenture (ACN) highlighted for its AI monetization and 60.1% fair-value upside. UBS reiterated a Buy rating on ACN with a $275 target. ACN's revenue grew 38% from 2021 to 2025, with a 22.9% ROIC and 13.7x forward P/E. Genpact (G) and FTI Consulting (FCN) are also mentioned, with lower valuations but different risks.

HighAI 9/10

TCS Emerges Ahead Of Accenture To Take Over Best Buy's India GCC Operations

TCS won a 5-year, Rs 2,000 crore deal to manage Best Buy's India GCC operations, beating Accenture. The Bengaluru center has 600 employees and covers data, analytics, and AI services. TCS offered competitive pricing and productivity improvements. The deal expands TCS's existing relationship with Best Buy, which generates $75-100 million annually in revenue, according to HFS Research.

$ACNMed

Q2 Earnings Recap: Gartner (NYSE:IT) Tops IT Services & Consulting Stocks

Accenture (NYSE:ACN) reported Q2 revenue of $18.72B, up 5.6% YoY, in line with expectations but missed guidance. IBM (NYSE:IBM) reported $17.16B, up 1.1% YoY, missing estimates by 1.5%. Kyndryl (NYSE:KD) reported $3.62B, down 3.3% YoY, missing revenue expectations but beating EPS estimates. ACN and IBM stocks are up 13.3% and 13.6% since reporting, while KD is down 8.5%.

$ACNMedAI 8/10

Accenture and AWS step up Middle East push into cloud and AI

Accenture and Amazon Web Services (AWS) signed a six-year deal to support Middle East businesses and governments in adopting cloud and AI technologies. The agreement focuses on modernizing legacy systems, migrating workloads, and deploying AI across sectors like energy and financial services. Gulf nations are investing heavily in AI infrastructure, with projects like the UAE's $30B UAE-US AI Campus and Saudi Arabia's 467MW data center capacity. AWS is also expanding in Saudi Arabia, with a new c

$ACNLow

ADHA sticks with Accenture for My Health Record support

The Australian Digital Health Agency (ADHA) awarded Accenture a $161.6M contract for My Health Record infrastructure services, running from 2026 to 2029 with an extension option. The deal covers the My Health Record system and ADHA's API gateway. ADHA CEO Amanda Cattermole noted over 25M active records and 207M clinician uses in the past year. Telstra Health secured a separate $33.2M contract for FHIR-based data architecture.

$KDLow

Q2 Rundown: Kyndryl (NYSE:KD) Vs Other IT Services & Consulting Stocks

Kyndryl (KD) reported Q2 revenue of $3.62B, down 3.3% YoY, missing estimates by 0.7% but beating EPS. Gartner (IT) reported $1.68B revenue, up 1.8% YoY, beating estimates. Accenture (ACN) reported $18.72B revenue, up 5.6% YoY, in line with estimates but missed guidance. IBM (IBM) reported $17.16B revenue, up 1.1% YoY, missing estimates by 1.5%. DXC (DXC) reported $3.00B revenue, down 5.1% YoY, in line with estimates but missed EPS.